Home » Topics » BioWorld Science

BioWorld Science
RSS

LIB-01 shows promise in rats with erectile dysfunction

Oct. 15, 2021

BenevolentAI nominates preclinical candidate for novel ulcerative colitis target

Oct. 15, 2021

IntoCell and Ab Studio establish research collaboration to combine antibody and linker capabilities

Oct. 15, 2021

RLY-2608, novel mutant and isoform selective inhibitor of PI3Kalpha

Oct. 15, 2021

CTX-III as a prognostic biomarker of fibrosis progression

Oct. 15, 2021

New TGF-beta receptor type-1 inhibitors described by Adlai Nortye

Oct. 15, 2021

Wigen Biomedicine Technology patents G12C mutant GTPase KRAS inhibitors

Oct. 15, 2021

Medshine Discovery discovers HBV cccDNA formation inhibitors

Oct. 15, 2021

Akebia Therapeutics presents new prolyl 4-hydroxylase inhibitors

Oct. 15, 2021

New EGFR inhibitors identified at Qilu Pharmaceutical

Oct. 15, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...